COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 1246: Articles 12451-12460  | Next

SARS-CoV-2 wastewater surveillance in Germany: long-term PCR monitoring, suitability of primer/probe combinations and biomarker stability
Ho, J., Stange, C., Suhrborg, R., Wurzbacher, C., Drewes, J. E., Tiehm, A.
10.1101/2021.09.16.21263575 — Posted: 2021-09-21
Influence of Built Environment on Bike Sharing Usage under COVID-19
Yang, H., Guo, Z., Huo, J., Yang, L.
10.1101/2021.09.17.21263721 — Posted: 2021-09-21
SARS-CoV-2 epidemic in the South American Southern cone: can combined immunity from vaccination and infection prevent the spread of Gamma and Lambda variants while easing restrictions?
Fiori, M., Bello, G., Wschebor, N., Lecumberry, F., Ferragut, A., Mordecki, E.
10.1101/2021.09.16.21263701 — Posted: 2021-09-21
Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults
Yorsaeng, R., Suntronwong, N., Phowatthanasathian, H., Assawakosri, S., Kanokudom, S., Thongmee, T., Vichaiwattana, P., Auphimai, C., Wongsrisang, L., Srimuan, D., Thatsanatorn, T., Klinfueng, S., Sudhinaraset, N., Wanlapakorn, N., Poovorawan, Y.
10.1101/2021.09.16.21263692 — Posted: 2021-09-21
The longitudinal kinetics of antibodies in COVID-19 recovered patients over 14 months
Eyran, T., Vaisman-Mentesh, A., Dror, Y., Aizik, L., Kigel, A., Rosenstein, S., Bahar, Y., Taussig, D., Tur-Kaspa, R., Kournos, T., Markovitch, D., Dicker, D., Wine, Y.
10.1101/2021.09.16.21263693 — Posted: 2021-09-21
Assessment of Environmental and Occupational Risk Factors for the Mitigation and Containment of a COVID-19 Outbreak in a Meat Processing Plant
Walshe, N., Fennelly, M., Hellebust, S., Wenger, J., Sodeau, J., Prentice, M., Grice, C., Jordan, V., Comerford, J., Downey, V., Perrotta, C., Mulcahy, G., Sammin, D.
10.1101/2021.09.17.21262959 — Posted: 2021-09-21
Association of inflammatory markers with severity of disease and mortality in COVID-19 patients: a systematic review and meta-analysis
Khan, S., Mishra, P., Parveen, R., Bajpai, R., Khan, M. A., Agarwal, N. B.
10.1101/2021.09.16.21263678 — Posted: 2021-09-21
Access to personal protective equipment in healthcare workers during the COVID-19 pandemic in the United Kingdom: results from a nationwide cohort study (UK-REACH)
Martin, C. A., Pan, D., Nazareth, J., Aujayeb, A., Bryant, L., Carr, S., Gray, L. J., Gregary, B., Gupta, A., Guyatt, A. L., Gopal, A., Hine, T., John, C., McManus, I. C., Melbourne, C., Nellums, L. B., Reza, R., Simpson, S., Tobin, M. D., Woolf, K., Zingwe, S., Khunti, K., Pareek, M., the UK-REACH Study Collaborative Group
10.1101/2021.09.16.21263629 — Posted: 2021-09-21
PCR test positive rate revealing the real infection epidemic status examined in the COVID-19 epidemic in Tokyo, Japan
Tomie, T.
10.1101/2021.09.15.21263609 — Posted: 2021-09-21
Dynamics of mask use as a prevention strategy against SARS-Cov-2 in Panama
Fernandez-Marin, H., Bruner-Montero, G., Portugal-Loayza, A. B., Miranda, V., Villareal, A., Ortega-Barria, E., Nunez-Samudio, V., Landires, I., Mejia, L. C. M. C. M., Lopez-Verges, S. L., Wcislo, W. T., Rao, J. K. S.
10.1101/2021.09.15.21263479 — Posted: 2021-09-21 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).